Campagna, Ryan A. J.
Carlson, Dustin A.
Hungness, Eric S.
Holmstrom, Amy L.
Pandolfino, John E.
Soper, Nathaniel J.
Teitelbaum, Ezra N.
Funding for this research was provided by:
National Institutes of Health (T32DK101363)
U.S. Public Health Service (R01 DK079902)
U.S. Public Health Service (P01 DK117824)
Article History
Received: 10 April 2019
Accepted: 19 July 2019
First Online: 2 August 2019
Compliance with ethical standards
:
: Dr. Carlson: Medtronic, Inc.—speaking, consulting, shared intellectual property rights and ownership surrounding functional luminal imaging probe panometry systems, methods, and apparatus. Dr. Hungness: Cook Medical—consulting; Boston Scientific—consulting. Dr. Pandolfino: Medtronic, Inc.—consulting, grant funding, speaking, consulting, shared intellectual property rights and ownership surrounding functional luminal imaging probe panometry systems, methods, and apparatus; Sandhill Scientific—consulting, speaking; Crospon—stock options; Takeda—speaking; AstraZeneca—speaking. Dr. Soper: Miret Surgical, Inc.—scientific advisory board, stock options; FlexDex, Inc.—scientific advisory board, stock options; MeshSuture, Inc.—scientific advisory board, stock options. Dr. Teitelbaum: Cook Medical—consulting; Boston Scientific—consulting. Drs. Campagna and Holmstrom: None.